MedTrace Logo

Eicosapentaenoic Acid Serum Levels in Patients With Gestational Diabetes

NCT05591664 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2022-10-24

No results posted yet for this study

Summary

In this study, we aim to compare the blood levels of Eicosapentaenoic acid (EPA) in gestational diabetes patients with normal pregnant women, to reveal the relationship between these markers, which are known to be effective on metabolic function, and gestational diabetes, and to contribute to future studies and possible treatment options.

Conditions

  • Gestational Diabetes

Interventions

DIAGNOSTIC_TEST

eicosapentaenoic acid

eicosapentaenoic acid levels of the groups will be monitored

Sponsors & Collaborators

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Principal Investigators

  • SENOL SENTURK · Recep Tayyip Erdogan University

Eligibility

Min Age
18 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2023-04-30
Completion
2023-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591664 on ClinicalTrials.gov